Immune reaction causes malaria organ damage

October 21, 2019

Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure. Researchers at the Max Planck Institute for Infection Biology in Berlin discovered a possible mechanism behind these complications. The malaria parasite triggers an immune reaction in the bloodstream that is intended for local defence. If the immune response escalates and acts systemically, it damages the patient's own tissue. This involves a white blood cell type that is highly abundant in the blood: the neutrophil.

Neutrophils are the most abundant white blood cells. Neutrophils identify and destroy harmful microorganisms that invade our body. Back in 2004, a research group led by Arturo Zychlinsky at the Max Planck Institute for Infection Biology discovered a special defense mechanism of neutrophils. The neutrophils react to pathogen contact by committing suicide; they disintegrate their cell and nuclear membrane and release network-like DNA structures that are called neutrophil extracellular traps or NETs. NETs can trap and kill microbes, but they are not only dangerous to the invaders. NETs can also attack the body's own tissue. It is therefore important that neutrophils are only activated locally and for a limited time.

Researchers from the research groups led by Arturo Zychlinsky and Borko Amulic showed that NETs could cause organ damage in malaria. The findings expand our understanding of typical malaria complications such as liver and kidney failure, pulmonary edema and brain swelling, which can lead to the death of the patient. About half a million people die of malaria every year.

No liver damage without NETs

In order to determine the role of NETs in malaria, the researchers used a special variant of the rodent malaria parasite in mouse experiments. This variant causes liver damage and therefore resembles severe malaria in humans. The researchers first observed a very high concentration of neutrophils and NETs in the blood of the infected mice. To find out if there was a link between NETs and the liver damage, they infected a group of genetically altered mice that could no longer form NETs. This allowed the team of researchers to examine the effect of NETs on disease progression. The results were clear - despite the same parasite burden, the mice without NETs did not develop liver damage.

"We were able to prove that a high concentration of NETs in the blood encourages the attachment of infected red blood cells to vessel walls as well as the recruitment of neutrophils - both are important causes of organ damage in the infected animals," explains the first author of the now published study, Lorenz Knackstedt. The accumulated blood cells clog the fine vessels in the organs. The lack of oxygen and bleeding from destroyed vessels can lead to total failure of the affected organ.

To show that the findings in the mouse model where relevant in malaria patients, the scientists examined blood samples from Gabon and Mozambique. A clear picture emerged here as well; the number of NETs in the blood increased immensely in cases of severe malaria. "The findings from our mouse experiments and the analysis of patient samples will help us understand malaria and diseases with similar severe symptoms," states Knackstedt. The described inflammatory responses are also present in systemic diseases like sepsis and systemic lupus erythematosus.
-end-
Original publication

S. Knackstedt, A. Georgiadou, F. Apel, U. Abu-Abed, C. A. Moxon, A. J. Cunnington, B. Raupach, D. Cunningham, J. Langhorne, R. Kruger, V. Barrera, S. P. Harding, A. Berg, S. Patel, K. Otterdal, B. Mordmüller, E. Schwarzer, V. Brinkmann, A. Zychlinsky and B. Amulic

Neutrophil extracellular traps drive inflammatory pathogenesis in malaria

Science Immunology; Oct. 18, 2019

Vol. 4, Issue 40, eaaw0336

Max-Planck-Gesellschaft

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.